Epigral Limited (EPIGRAL) reports a 25% YOY increase in PAT for Q1FY27 to ₹ 99 Cr, announces ₹ 600 crore capex for new Epoxy Resin plant.
Epigral Limited reports record Q4FY26 revenue of Rs 736 Cr, up 17%, driven by strong demand and operational efficiencies.
Epigral Limited FY2026 results highlight strong growth, record revenue, and strategic expansions.